Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Intradermal testing can better detect corticosteroid allergies than patch testing.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

Allergies, especially both seasonal and food, increase the risk of developing alopecia areata.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Cetirizine is effective and safe for treating various allergies, with personalized dosing improving its use.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Pets can have food allergies causing itching and skin issues, needing a special diet for diagnosis.

ChatGPT-4 can help with allergic contact dermatitis but shouldn't replace expert doctors.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Upadacitinib improved multiple immune-related conditions in one patient.

Children with atopic diseases have a higher risk of developing alopecia areata.